Cytokinetics CYTK Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's shares (diluted)?
- Cytokinetics (CYTK) reported shares (diluted) of 123.3M in Q1 2026.
- How has Cytokinetics's shares (diluted) changed year-over-year?
- Cytokinetics's shares (diluted) increased by 4.0% year-over-year, from 118.5M to 123.3M.
- What is the long-term trend for Cytokinetics's shares (diluted)?
- Over 4 years (2021 to 2025), Cytokinetics's shares (diluted) has grown at a 12.3% compound annual growth rate (CAGR), from 300.2M to 478M.
- What does shares (diluted) mean?
- The total number of shares that would exist if all potential stock options and convertible debt were converted.
- How do you interpret shares (diluted)?
- A rising number indicates potential future dilution for current shareholders due to stock-based compensation or financing activities.
- How does shares (diluted) compare across companies?
- Standard metric for all public companies to assess potential dilution.